Loading...
Changes in body mass index in boys with central precocious puberty over 2 years of gonadotropin-releasing hormone agonist therapy
PURPOSE: Gonadotropin-releasing hormone agonist (GnRHa) is a safe and effective therapy used to treat central precocious puberty (CPP). Although most studies have reported no significant difference in body mass index (BMI) in girls during and after GnRHa therapy, few studies have investigated change...
Na minha lista:
| Udgivet i: | Ann Pediatr Endocrinol Metab |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Society of Pediatric Endocrinology
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7538302/ https://ncbi.nlm.nih.gov/pubmed/33017886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6065/apem.1938176.088 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|